Event content

Rapid and efficient development of drug candidates is increasingly important for pharmaceutical companies with accelerated timelines and funding constraints. However, many early drug candidates have poor oral absorption properties making it challenging to achieve target pharmacokinetic (PK) profiles. Witho...

With the industry digitally evolving, you and your team need to keep up and not be left behind. Join and take part in our panel and learn how to equip and prepare yourself with the latest digital tools in pharma: • Assessing what resources and training services are available • Introducing practical...

With US Pharma pledging to become net-zero by 2050, you must have the right processes. Join our focused panel where our experts will discuss the best ways to implement ESG in your organization: • Defining ESG in Pharma to understand what makes it different from other industries • Establishing what i...

• GUCY2C is a mucosally-restricted, immunologically compartmentalized self-antigen overexpressed in GI adenocarcinomas • GUCY2C Vaccination in MRD (minimal residual disease) setting for recurrence prevention • GUCY2C adoptive cell therapy for treatment of metastatic GI cancers

For the past 20 years in healthcare, Polypropylene (PP) has been the most utilized plastic across a range of applications, from high-risk applications such as IV parenteral packaging to medical devices and diagnostics. PP offers alternatives to glass, metal and other plastics, such as PS or PVC. The press...

• Market needs for a device to deliver high drug loads to lungs. • Introduction to the Orbital device – features and benefits. • Comparative performance of Orbital to other DPI devices. • Different types of molecules and formulations made using different particle engineering technologies, inc...

Connecting medication and medical devices to the internet can enhance product protection, improve patient safety and outcomes, and optimize processes along complex supply chains. NFC-RFID technologies are increasingly used to provide connectivity benefits more securely and efficiently, ensuring that pharma...

Human Factors Engineering (HFE) process participates in the product development for a safe and effective use by the end-user population. HFE data are under agencies' scrutiny as part of the design control of a drug - device combination product. Timely planning can be challenging during combination product ...

• A review of how big pharma has reacted to the trend: who is going virtual with their trials? • The usage data of virtual trial elements pre and post pandemic • Predictions for the future

This session will help you understand real-world life as a student entering the Pharma industry post-pandemic. We will learn more about the role a CDMO plays in the pharmaceutical industry and the importance of hiring university and school early careers from the lens of a business leader. Finally, we will ...

Pharmaceutical and Biotechnology companies are exposed to more than their fair share of ESG risks, that, if not addressed properly, can have significant financial and reputational impacts in the long run. To measure a company’s level of exposure with industry-specific material ESG risks and how well a comp...

The next generation enteric capsule enables pharmaceutical companies to develop a targeted delivery solution while simplifying their manufacturing processes.

The solution offers: • An acid-protective dosage form with enteric drug release through a patient centric delivery solution; • A sim...

In this webinar, originally broadcast as a part of Pharmapack Europe 2022, Mayur Patel, Digital Health Expert, PA Consulting discusses in this session how every day 14,000 tons of medical waste are generated at healthcare facilities across the U.S. alone. Up to 20-25% of this waste can be attributed to pl...

In this webinar, originally broadcast as a part of Pharmapack Europe 2022, speakers from STERIS will be describing the methodology for transferring the sterilization process of medical or pharma products from one radiation technology to another (e.g. gamma to X-ray).

In this webinar, originally broadcast as part of the Pharmapack Europe show, Dr. Robert Lindner, Global Product Manager RTU Vials, SCHOTT AG will discuss how sterile integrity is indispensable in aseptic fill-and-finish operations. Pharmaceutical companies pay highest attention to producing high quality d...

In this webinar, originally broadcast as a part of Pharmapack Europe, Eve-Marie Vaccaro, Global Sales & Operation Planner, and Edgar Bauer, Global Key Account Manager Bausch+Ströbel from BD Medical - Pharmaceutical Systems discuss how VHP sterilization is a viable alternative for ensuring improved patient ...

This discussion will focus on four critical areas for process development and overall product life cycle management: Quality, Scalability, COGS and Sustainability Strategies for accelerating process development in efforts to initiate clinical trials quicker will also be discussed Examples, from both ...

As global governments and businesses increasingly make bold claims and commitments to tackle the climate emergency, investors are starting to take note by using the ESG framework to move beyond environmental concerns and focus on a company's impact on all the different ecosystems it operates in. The ris...

Discuss strategies and methodologies to develop scalable, robust, and cost-effective manufacturing processes for allogeneic cell therapies Showcase how induced pluripotent stem cells (iPSC) are being used as renewable sources of allogeneic cancer therapies Demonstrate the criticality of GMP manufacturing...

In this webinar, originally broadcast as part of CPHI NA, Michael Sassano, CEO and Chairman, Somai Pharmaceuticals discusses: • Global Pharmaceutical Cannabis market and the history of recent growth • Current trends in the Medical Cannabis market versus the Canadian and American experience • Herbal M...